Author:
Zhou Shujie,Xie Jingjing,Huang Zhaoqin,Deng Liufu,Wu Leilei,Yu Jinming,Meng Xiangjiao
Funder
National Key Research and Development Program of China
National Natural Science Foundation of China
Natural Science Foundation of Shandong Province
Reference126 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2018
2. The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer;Peters;Canc. Treat Rev.,2016
3. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma;Schouten;Canc.-Am. Canc. Soc.,2002
4. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study;Cagney;Neuro Oncol.,2017
5. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial;Mok;Lancet,2019
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献